Motivations and concerns of women considering genetic testing for breast cancer: A comparison between affected and at-risk probands

被引:21
作者
Brandt, R
Hartmann, E
Ali, Z
Tucci, R
Gilman, P
机构
[1] Lankenau Hosp, Canc Risk Assessment Program, Wynnewood, PA 19096 USA
[2] Thomas Jefferson Univ, Sch Med, Philadelphia, PA 19107 USA
来源
GENETIC TESTING | 2002年 / 6卷 / 03期
关键词
D O I
10.1089/109065702761403360
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Since the discovery of the BRCA1 and BRCA2 genes, there has been an increasing demand for breast cancer risk assessment programs. In an effort to understand and serve the population such programs target better, several studies have identified factors influencing high-risk women to pursue breast cancer risk assessment and genetic testing services; none, however, has focused on how the motivations and concerns of at-risk women may differ from their previously affected counterparts, who are typically the initial members of their families to undergo genetic testing. The majority of both previously affected and unaffected women felt that preventative surgery decisions, surveillance practices, the assessment of children's risks, and increased breast cancer anxiety were "more important" or "very important" issues regarding their thoughts about genetic testing. Significantly more affected women deemed family members' opinions "more" or "very important" (p < 0.01). Opinions concerning insurance and employment discrimination did not vary significantly between groups; however, a larger percentage of affected women felt this issue was of importance. Although all issues above should be addressed with women seeking cancer risk assessment and genetic testing, this research may help health care providers to gain a greater understanding of how the motivators and concerns of high-risk women can differ with personal cancer status so that referral, counseling, and education can be executed optimally.
引用
收藏
页码:203 / 205
页数:3
相关论文
共 18 条
[11]   All in the family:: Evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results [J].
Hughes, C ;
Lerman, C ;
Schwartz, M ;
Peshkin, BN ;
Wenzel, L ;
Narod, S ;
Corio, C ;
Tercyak, KP ;
Hanna, D ;
Isaacs, C ;
Main, D .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 107 (02) :143-150
[12]   Psychological aspects of cancer screening in high-risk populations [J].
Kash, KM ;
Dabney, MR .
MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (05) :519-524
[13]   What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination [J].
Matloff, ET ;
Shappell, H ;
Brierley, K ;
Bernhardt, BA ;
McKinnon, W ;
Peshkin, BN .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) :2484-2492
[14]  
Peterson EA, 2002, CANCER EPIDEM BIOMAR, V11, P79
[15]  
Rimer BK, 1996, CANCER, V77, P2348, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2348::AID-CNCR25>3.0.CO
[16]  
2-W
[17]   Genetic counseling for BRCA1/BRCA2 testing [J].
Schneider, KA .
GENETIC TESTING, 1997, 1 (02) :91-98
[18]   The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer [J].
Watson, M ;
Lloyd, S ;
Davidson, J ;
Meyer, L ;
Eeles, R ;
Ebbs, S ;
Murday, V .
BRITISH JOURNAL OF CANCER, 1999, 79 (5-6) :868-874